Takeda Pharmaceuticals U.S.A., Inc.

May 17, 2019

U.S. FDA Approves GATTEX® (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)

Apr 02, 2019

Motegrity(TM) (prucalopride), the Only Serotonin-4 Receptor Agonist for Adults with Chronic Idiopathic Constipation (CIC), is Now Available in the United States

May 02, 2018

TRINTELLIX® (vortioxetine) Prescribing Information Now Includes New Data Showing Improvement in Processing Speed, an Important Aspect of Cognitive Function in Acute Major Depressive Disorder (MDD)

Nov 17, 2017

The Boston Globe Names Takeda Pharmaceuticals U.S.A., Inc. a Top Place to Work for 2017

Nov 17, 2017

Takeda and Cognition Kit Present Results from Digital Wearable Technology Study in patients with Major Depressive Disorder (MDD)

Nov 10, 2017

The Chicago Tribune Names Takeda Pharmaceuticals U.S.A., Inc. A Workplace Achiever of the Chicago Area 2017 Top Workplaces Award

Nov 06, 2017

Takeda, Lundbeck and Advocate Health Care Research Study Aims to Enhance Patient-Provider Engagement in Major Depressive Disorder Treatment using Digital Technology

Oct 06, 2017

Takeda Donates $100,000 to Local, Regional Charities as Part of Company's Takeda Cares Day Event

Oct 04, 2017

Takeda Welcomes The Honorable Susana Mendoza As Guest Speaker At Deerfield Headquarters To Celebrate Company's Commitment to Latino Culture